Getting ahead of misinformation around anti-HIV injection Lenacapavir
Image credit: MasterTux on Pixabay.
In this Bhekisisa op-ed, Dr Brendan Maughan-Brown discusses how misinformation could suppress demand for Lenacapavir, or LEN - the twice-a-year injection that essentially eliminates the risk of getting HIV. He discusses what we can do to curb the effects of misinformation and why the window to get ahead of it is open right now. In an attempt to counter misinformation that could discourage young women from getting the pre-exposure prophylaxis, or PrEP, Maughan-Brown and research colleagues Alison Buttenheim and Harsha Thirumurthy created a series of short TikTok videos. The videos are designed to “pre-bunk” misinformation about LEN, preparing audiences to recognise potential misinformation about it before they encounter it online. Read more.